Crossref
Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance
Journal of Clinical and Basic Research · 2022
DOI: 10.61186/jcbr.6.4.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Basic Research, 2022. Verfasst von Saffalya Nayak und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nayak, S., & Mohapatra, D. (2022). Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance. Journal of Clinical and Basic Research. https://doi.org/10.61186/jcbr.6.4.19
Vancouver
Nayak S, Mohapatra D. Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance. Journal of Clinical and Basic Research. 2022. doi:10.61186/jcbr.6.4.19
BibTeX
@article{Nayak2022,
author = {Nayak, Saffalya and Mohapatra, Debjyoti},
title = {Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance},
journal = {Journal of Clinical and Basic Research},
year = {2022},
doi = {10.61186/jcbr.6.4.19}
}
EUVIMED